Who will speak for cardiac CT? Apparently, no one, when the setting is the annual business meeting of the Society for Cardiovascular Magnetic Resonance.
Who will speak for cardiac CT? Apparently, no one, when the setting is the annual business meeting of the Society for Cardiovascular Magnetic Resonance.
SCMR leaders have debated for years whether the society's mission should include CT. Sparked by explosive growth of cardiac CT and the formation of the Society of Cardiovascular Computed Tomography, the issue was the subject of passionate debate at the society's annual board meeting in January, according to president Dr. Warren Manning.
The SCCT has attracted 2000 members within its first few months, compared with the 1400 members who have signed on with the SCMR in its 10-year history.
A few days later during the regular meeting, Manning invited all members to debate the proposal. Only three chose to do so-all opposed to the idea of adding CT to the society's mission. An audience of 700 attended the session.
Dr. Nathaniel Reichek, director of research at St. Francis Hospital Heart Center in Roslyn, NY, expressed fear that interest in cardiac MR would diminish if the society attempted to serve both communities.
Dr. Leon Axel, director of cardiac imaging at NYU School of Medicine, emphasized that the strength of the society lies in its clear focus on MR and the diversity within that focus among basic scientists, physicians, engineers, radiologists, and cardiologists who have developed and applied the technology.
Dr. Dudley Pennell, director of cardiac MR at Royal Brompton Hospital in London, expressed concern that the progression of cardiac MR research could lose momentum if it loses the SCMR as an incubator for technical innovation and its annual meeting as a showcase for its best work.
"This group is quite definitely recognized as the premier world society for cardiovascular MR. I don't see that continuing with a dual focus," he said.
The SCMR board plans to address the question of the society's mission in a mail-in referendum addressed to all members. Results will be announced later this year.
New CT and MRI Research Shows Link Between LR-M Lesions and Rapid Progression of Early-Stage HCC
January 2nd 2025Seventy percent of LR-M hepatocellular carcinoma (HCC) cases were associated with rapid growth in comparison to 12.5 percent of LR-4 HCCs and 28.5 percent of LR-4 HCCs, according to a new study.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can AI Facilitate Single-Phase CT Acquisition for COPD Diagnosis and Staging?
December 12th 2024The authors of a new study found that deep learning assessment of single-phase CT scans provides comparable within-one stage accuracies to multiphase CT for detecting and staging chronic obstructive pulmonary disease (COPD).
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.